These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8461267)

  • 21. Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine.
    Freo U; Ricciardi E; Pietrini P; Schapiro MB; Rapoport SI; Furey ML
    Am J Psychiatry; 2005 Nov; 162(11):2061-70. PubMed ID: 16263845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
    Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
    Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning.
    Young SL; Bohenek DL; Fanselow MS
    Neurobiol Learn Mem; 1995 Mar; 63(2):174-80. PubMed ID: 7663891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning.
    Moran PM
    Behav Brain Res; 1992 Jun; 48(2):187-97. PubMed ID: 1616609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic-adrenergic balance: Part 1. Relationship between central and peripheral sensitivities.
    Fritze J; Sofic E; Müller T; Pfüller H; Lanczik M; Riederer P
    Psychiatry Res; 1990 Dec; 34(3):259-70. PubMed ID: 1963691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid induction of supersensitivity to muscarinic antagonists-induced motor excitation by continuous stimulation of cholinergic receptors.
    Fernando JC; Hoskins B; Ho IK
    Life Sci; 1985 Sep; 37(9):883-92. PubMed ID: 4041002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of cholinergic system on myoclonus in myoclonic epilepsies.
    Rektor I; Svejdová M; Silva-Barrat C; Menini C
    Mov Disord; 1992; 7(3):224-7. PubMed ID: 1620139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.
    Walker DL; McGlynn T; Grey C; Ragozzino M; Gold PE
    Psychopharmacology (Berl); 1991; 105(1):57-62. PubMed ID: 1745712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Central anticholinergic syndrome during postoperative period].
    Rupreht J; Dworacek B
    Ann Fr Anesth Reanim; 1990; 9(3):295-304. PubMed ID: 2196841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the startle reaction by physostigmine in patients with early brain damage.
    Rektor I; Svejdová M
    Acta Neurol Scand; 1992 Sep; 86(3):312-6. PubMed ID: 1414253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cholinergic stimulation on pituitary hormone release.
    Davis BM; Brown GM; Miller M; Friesen HG; Kastin AJ; Davis KL
    Psychoneuroendocrinology; 1982; 7(4):347-54. PubMed ID: 6132424
    [No Abstract]   [Full Text] [Related]  

  • 35. Central cardiovascular effects of physostigmine in anesthetized cats.
    Hara Y; Ally A; Murayama S
    Neuropharmacology; 1992 Sep; 31(9):923-8. PubMed ID: 1436399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relearning at different times after training as affected by centrally and peripherally acting cholinergic drugs in the mouse.
    Squire LR; Glick SD; Goldfarb J
    J Comp Physiol Psychol; 1971 Jan; 74(1):41-5. PubMed ID: 5163699
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.
    Wesnes K; Warburton DM
    Neuropsychobiology; 1983; 9(2-3):154-7. PubMed ID: 6621852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic regulation of sexual behavior in female hamsters.
    Dohanich GP; McMullan DM; Brazier MM
    Physiol Behav; 1990 Jan; 47(1):127-31. PubMed ID: 2326327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine treatment and fimbria-fornix lesions: mimetic effects on radial maze performance.
    Cassel JC; Kelche C
    Physiol Behav; 1989 Sep; 46(3):347-53. PubMed ID: 2623054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
    Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M
    Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.